Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Comment by jjshantzon Dec 19, 2017 12:30pm

138 Views

Post# 27187801

RE:RE:Penny Flippers will....

Are you guys new..lol.. do you not see that the SP is being held down for a reason, every half sent on the ask is coming with a big wall resistance... which is a huge indication that accumulation is being had at lower prices and all signs point to another nr real soon as was mentioned on here previously.. just my two cents..

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario